Answers are grounded in this paper and cite their sources.
Comparative analysis reveals BRAF V600E detection in colorectal cancer, highlighting FoundationOne's validity.
Contingency table comparing BRAFV600E status between the CTA and F1LCDx
No takes yet. Share an insight, caveat, or question.
Yaeger et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: